drugset / Trial / NCT00474799
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to characterize the repeat dosing plasma profile, extent of accumulation and repeat dose pharmacokinetics of morphine, morphine-3-glucuronide, and morphine-6-glucuronide during administration of MNS075 in two different, clinically-relevant dosing schedules.
Timeline
- Start
- 2007-01
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 7.5 mg | Intranasal |
| Subject | Morphine | Other / unclassified | 15 mg | Intranasal |
Indications
No indication recorded.